Pasaje de la Cárcova 3526 ARG
(54 11) 4963-7941

PLENARY SESSION 1

Focal treatment for prostate cancer with HIFU, functional and oncological results.

RM FusionWith Ultrasound, for all patients (NO)

Bladder CIS, where are we?

Partial nephrectomy, how have we advanced?

Robotic radical cystectomy, advantages of intracorporeal neobladder

RM FusionWith Ultrasound, for all patients (YES)

Penile cancer: update in diagnosis and treatment

Sarcopenia and nutrition as predictive factors in the results of radical cystectomy

PLENARY SESSION 2

Radical prostatectomy after radiotherapy or brachytherapy; really worth it?

Theranostic in prostate cancer; Exaggeration or hope?

Urethral surgery in men and women

Management of asymptomatic bacteriuria and recurrent urinary infections

Complications in Laparoscopic and Robotic Surgery

SIMPOSIO ASTELLAS

Early identification of the patient and impact of comorbidities in the therapeutic decision in castration resistant prostate cancer (CRPC)

Early identification of the patient and impact of comorbidities in the therapeutic decision in castration resistant prostate cancer (CRPC)

Early identification of the patient and impact of comorbidities in the therapeutic decision in castration resistant prostate cancer (CRPC)

Facebook
Twitter
Instagram
YouTube
WhatsApp